The United Kingdom’s cancer death rate has never been lower. New data from Cancer Research UK shows that around 247 people per 100,000 died from cancer each year between 2022 and 2024 — a 29% drop from the peak of 355 deaths per 100,000 recorded in 1989. That decline, built over more than three decades, reflects advances in screening, treatment, and prevention that now reach millions of people across the country.
- UK cancer death rates fell 11% in just the past decade, according to Cancer Research UK’s latest analysis — meaning the pace of progress is accelerating, not slowing.
- Stomach cancer deaths dropped 34% over 10 years, lung cancer deaths fell 22%, ovarian cancer deaths declined 19%, and breast cancer deaths fell 14%.
- Cervical cancer has seen one of the largest long-term improvements of any cancer type, with death rates down 75% since the 1970s — driven by NHS screening programs and, more recently, the HPV vaccine introduced in 2008.
The data covers all four UK nations and draws on decades of mortality tracking. Dr. Sam Godfrey, science engagement lead at Cancer Research UK, said the figures represent the cumulative effect of scientific breakthroughs ranging from vaccines to more targeted treatments — and that thousands more people each year now reach milestones and moments they would not have reached a generation ago.
What’s actually driving the decline
No single factor explains a 29% drop across all cancer types over 35 years. Several distinct threads run through the data.
Screening programs for breast, bowel, and cervical cancers have steadily pushed earlier detection — and earlier detection is still one of the most reliable predictors of survival. The NHS cervical screening program alone has been contributing to falling cervical cancer rates since the 1970s, identifying pre-cancerous changes before they can develop into invasive disease.
The HPV vaccine, introduced in UK schools in 2008 and now received by at least 6.5 million people, is expected to prevent 90% of all cervical cancer cases. However, because the virus takes 25 to 30 years to progress from infection to invasive cancer, researchers note that the full measurable impact of the vaccine on cancer death rates will not appear until around 2040. The decline in cervical cancer mortality so far reflects decades of screening progress, with the vaccine’s contribution still accumulating.
Smoking policy has also played a sustained role. UK tobacco control measures — including bans on indoor smoking, restrictions on advertising, and plain packaging requirements — have contributed to falling lung cancer rates that are now 22% lower than a decade ago.
The treatments that changed the numbers
Cancer Research UK highlights several specific research milestones that have moved the mortality figures over time.
Abiraterone, a drug that blocks testosterone from fueling prostate cancer growth, emerged from Cancer Research UK-funded science and is now used by hundreds of thousands of patients worldwide. The NHS recently expanded access to abiraterone in England, making it available to thousands more men each year. Prostate cancer death rates have fallen 11% over the past decade.
Researchers also identified EGFR, a molecule that drives certain lung cancers, which opened the door to a generation of targeted treatments that attack specific DNA changes in tumor cells rather than using broad chemotherapy. Those precision medicines are now being combined with immunotherapy in newer trials.
For brain tumors — one of the areas with the least progress and the most urgent remaining need — the drug temozolomide, trialed by Cancer Research UK researchers and approved in the 2000s, extended survival for people with glioblastoma. Death rates for brain and central nervous system cancers have fallen 6% for men and 8% for women over the past decade, a modest but meaningful shift in a category where outcomes have historically been poor.
What the numbers don’t capture
Progress in aggregate mortality rates can obscure serious disparities. Not every cancer type is moving in the right direction.
Liver cancer deaths rose 14% over the past decade, gallbladder cancer deaths climbed 29%, and womb and head and neck cancer mortality rates have also increased. These cancers share a pattern: symptoms tend to appear late, when the disease is already advanced, and effective early detection tools remain limited.
A growing and aging population also means that even as death rates per 100,000 fall, the total number of people dying from cancer continues to rise. Rates and raw numbers can tell different stories simultaneously — and the NHS, under significant financial pressure across all four nations, faces real capacity challenges that could slow future progress if unaddressed.
What comes next
Researchers at Cancer Research UK are now developing cancer vaccines that go beyond the HPV model — training the immune system to recognize and clear cells that have the potential to become cancerous before they do. LungVax, OvarianVax, and LynchVax are all in active development or early trials, targeting lung cancer, ovarian cancer, and Lynch syndrome-related cancers respectively.
England’s newly published National Cancer Plan sets out ambitions to accelerate clinical trial setup and expand NHS research capacity. Cancer Research UK is pushing Welsh and Scottish governments to match that commitment ahead of 2026 elections in both nations — arguing that a coordinated UK-wide approach is essential to sustaining the progress the data now confirms.
The 29% drop since 1989 is real and hard-won. The 11% drop in a single decade suggests it is also accelerating. Whether that pace holds will depend on how much political will, research funding, and NHS capacity the UK is prepared to commit to the work still ahead.
This story was originally reported by Cancer Research UK.
More Good News
-
U.K. cancer death rates down to their lowest level on record
Cancer Research UK data published in March 2026 confirms that UK cancer death rates have reached their lowest level on record — around 247 deaths per 100,000 people annually between 2022 and 2024, down 29% from the 1989 peak of 355 per 100,000. The rate fell 11% in just the past decade, with stomach cancer deaths down 34%, lung cancer down 22%, and ovarian cancer down 19%. Cervical cancer death rates have dropped 75% since the 1970s, driven by NHS screening programs and the HPV vaccine introduced in 2008. Researchers caution that liver, womb, and gallbladder cancer death rates are…
-
California condors nesting in Pacific Northwest for first time in a century
A pair of California condors reintroduced by the Yurok Tribe appear to be incubating the first egg in the Pacific Northwest in more than a century, nesting inside a hollow old-growth redwood in Redwood National Park in early February 2026. The female, named Ney-gem’ Ne-chween-kah — Yurok for “She carries our prayers” — and her mate were among the first cohort released in 2022 as part of the Northern California Condor Restoration Program. The species fell to just 22 individuals in 1982 and has since recovered to 607. The Yurok Tribe began working toward this moment in 2003, driven by…
-
Canada commits $3.8 billion to protect 30% of the country’s land and water by 2030
Prime Minister Mark Carney announced Canada’s $3.8 billion nature conservation strategy on March 31, 2026, committing the world’s second-largest country to protect 30% of its land and 28% of its marine territory by 2030. Two sites launched immediately: the Wiinipaawk Indigenous Protected Area in eastern James Bay and the Seal River Watershed National Park in Manitoba, one of the world’s largest intact watersheds at 50,000 square kilometers. The plan expands the Indigenous Guardians Program by $230 million. Conservation experts say implementation accountability, not the dollar figure, will determine whether Canada’s biodiversity commitments hold this time.
-
The U.N. grants international protection to 40 new migratory species
At the CMS COP15 summit in Campo Grande, Brazil, 132 nations expanded UN migratory species protections on March 29, 2026, adding 40 animals — including the snowy owl, giant otter, striped hyena, and great hammerhead shark — to the treaty’s legally binding protection lists. The Convention on the Conservation of Migratory Species now covers more than 1,200 unique species. A new UN interim report released at the summit found that 49% of already-protected species populations are declining and 24% face extinction. The decisions set binding conservation obligations for member nations and signal that coordinated international action remains the strongest tool…
-
Washington state enacts historic millionaires’ tax
Washington Gov. Bob Ferguson signed the Millionaires’ Tax into law on March 30, 2026, creating the state’s first-ever tax on income above $1 million. Less than half of 1% of residents will pay it — but millions will benefit. The revenue funds free K-12 school meals, expands the Working Families Tax Credit to 460,000 additional households, cuts taxes for 138,000 small businesses, and invests more than $320 million in affordable childcare. After nearly a century of one of the most regressive tax structures in the country, Washington is rewriting the rules.